Backs FY23 revenue growth view of up 6.5%-7%, consensus $7.4B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ZBH:
- Zimmer Biomet Announces Leadership Transition
- Zimmer Biomet price target raised to $125 from $116 at UBS
- Zimmer Biomet price target raised to $120 from $116 at Barclays
- Zimmer Biomet raises FY23 adjusted EPS view to $7.47-$7.57 from $7.40-$7.50
- Zimmer Biomet reports Q2 adjusted EPS $1.82, consensus $1.81